{"title":"[New concepts in perioperative refined management of liver resection for hepatocellular carcinoma].","authors":"T Yuan, Z Y Huang","doi":"10.3760/cma.j.cn112139-20260409-00148","DOIUrl":null,"url":null,"abstract":"<p><p>Liver resection for hepatocellular carcinoma (HCC) still faces the dual challenges of operative safety and high postoperative recurrence. Traditional precision surgery mainly focuses on operative manipulation, whereas the concept of scientific hepatectomy incorporates cirrhosis background, tumor biological behavior, and coordination with systemic therapy into a unified decision-making framework. This article discusses perioperative refined management strategies guided by scientific hepatectomy. Preoperatively, the severity of cirrhosis should be evaluated to define the safe extent of resection. Intraoperatively, oncological radicality should be balanced against liver parenchymal preservation. During the perioperative period, neoadjuvant therapy, conversion therapy, and adjuvant therapy should be integrated to promote the transition of HCC surgery toward comprehensive treatment. The focus of scientific hepatectomy is not merely to improve operative precision, but to select a more appropriate resection timing, resection extent, and treatment coordination strategy according to cirrhosis severity, tumor biological risk, and the need for subsequent treatment.</p>","PeriodicalId":60685,"journal":{"name":"中华外科杂志","volume":"64 10","pages":"1035-1039"},"PeriodicalIF":0.0000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华外科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/cma.j.cn112139-20260409-00148","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Liver resection for hepatocellular carcinoma (HCC) still faces the dual challenges of operative safety and high postoperative recurrence. Traditional precision surgery mainly focuses on operative manipulation, whereas the concept of scientific hepatectomy incorporates cirrhosis background, tumor biological behavior, and coordination with systemic therapy into a unified decision-making framework. This article discusses perioperative refined management strategies guided by scientific hepatectomy. Preoperatively, the severity of cirrhosis should be evaluated to define the safe extent of resection. Intraoperatively, oncological radicality should be balanced against liver parenchymal preservation. During the perioperative period, neoadjuvant therapy, conversion therapy, and adjuvant therapy should be integrated to promote the transition of HCC surgery toward comprehensive treatment. The focus of scientific hepatectomy is not merely to improve operative precision, but to select a more appropriate resection timing, resection extent, and treatment coordination strategy according to cirrhosis severity, tumor biological risk, and the need for subsequent treatment.
期刊介绍:
Chinese Journal of Surgery|Chin J Surg (monthly) is a high-level medical science and technology journal approved by the General Administration of Press and Publication of the People's Republic of China, under the supervision of the China Association for Science and Technology, and organised by the Chinese Medical Association for domestic and international public circulation. It was founded in January 1951, and is published on the basis of the Journal of Chinese Surgery. The Journal is aimed at senior and intermediate surgeons and related researchers, mainly reporting the leading scientific research results and clinical experience in the field of surgery, as well as the basic theoretical research that has a guiding effect on the clinical work of surgery.
Chinese Journal of Surgery|Chin J Surg is committed to reflecting the major research progress in the field of surgery in China and promoting academic exchanges at home and abroad. The main columns include thesis, meta-analysis, review, expert forum, synthesis, case report, diagnosis and treatment experience, technical exchange, clinical case discussion, academic controversy, and special lectures, etc. The journal has been accepted by the National Academy of Medicine of the United States. The journal has been included in many famous databases at home and abroad, such as the Biomedical Analysis and Online Retrieval System (MEDLINE) of the U.S. National Library of Medicine.